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Peripheral nerve sheath tumors (PNSTs) comprise a heterogeneous group of  neoplasms 
originating from the elements of  the nerve sheath. They are divided into two forms: 
benign and malignant PNST. Both benign and malignant PNSTs are not very common 
in domestic animals but they are reported in different animal species. Histologically, 
PNSTs are composed predominantly of  spindle cells arranged in bundles, whorls and 
sheets, with a different number of  pleomorphic cells and mitotic fi gures. 
The aim of  this study was a reclassifi cation of  17 dog tumor samples initially diagnosed 
with peripheral nerve sheath tumors using histopathological analysis. The main criterion 
for reclassifi cation was immunohistochemical positivity for various antigens.
PNSTs are often histologically very similar to other spindle cell tumors and 
immunohistochemistry is required for differential diagnosis. PNSTs generally express 
vimentin, S-100 protein, glial fi brillary acidic protein (GFAP), collagen IV and laminin. 
Four tumor samples were positive to muscular marker α-SMA and vimentin and 
negative for S-100 protein and desmin. The spindle cells whirling around some blood 
vessels were observed in these tumors so they were reclassifi ed as perivascular wall 
tumors (PWTs). The other 13 tumors were S-100 protein and vimentin positive and 
α-SMA and desmin negative, thus classifi ed as PNST.
The use of  the immunohistochemical panel is necessary for distinguishing PNSTs from 
PWTs in routine diagnostics. 
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INTRODUCTION
Peripheral nerve sheath tumors (PNSTs) comprise a heterogeneous group of  
neoplasms originating from the elements of  the nerve sheath, such as Schwann cells, 
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perineural cells and intraneural fi broblasts. Generally, the term schwannoma presents 
a tumor composed solely of  cells originated from Schwann cells, while neurofi broma/
sarcoma is composed of  Schwann cells and perineural cells [1,2]. According to 
morphologic features and biologic behavior, PNSTs are divided into two forms: 
benign PNST (BPNST) and malignant PNST (MPNST) [3]. Generally, BPNSTs are 
not very common in domestic animals but they are reported in different animal species, 
such as cat, horse, pig and goat [4-7] and most frequently are seen in dogs and cattle 
[8,9]. Likewise, MPNSTs are rare in animals and in dogs, they account for 27% of  all 
nervous system tumors [1,10]. Middle-aged or older animals are more predisposed to 
develop PNSTs [2,11].
Histologically, benign tumors of  peripheral nerve sheath are usually well circumscribed, 
encapsulated and composed predominantly of  spindle cells arranged in bundles 
and sheets [12]. The slightly polymorphic neoplastic cells could be separated by a 
collagenous matrix and form concentric whorls (Antoni type A pattern) or the cellular 
density could be reduced and cells surrounded by loose fi brous to mucinous stroma 
(Antoni type B pattern) [13,14]. The double row of  palisading tumor cells, known as 
Verocay bodies, is rarely observed [15].
Microscopically, malignant tumors of  peripheral nerve sheath are non-encapsulated 
and consist of  usually highly pleomorphic cells with numerous mitotic fi gures [12,13]. 
Neoplastic cells are arranged in fascicles, whorls or sheets and embedded in a fi brillar 
collagenous stroma. MPNSTs have an infi ltrative growth pattern and metastasize to 
distant organs [13,14]. Areas of  glandular, rhabdomyoblastic squamous, cartilaginous 
or osteoid differentiation may be seen occasionally [12,13]. 
PNSTs generally express vimentin, S-100 protein, glial fi brillary acidic protein (GFAP), 
collagen IV and laminin. Unlike BPNSTs, malignant forms of  PNST are usually S-100 
protein negative [11,16]. Immunohistochemical staining is very important since PNSTs 
are often histologically very similar to other sarcomas and distinguishing these tumors 
from other soft tissue tumors, especially perivascular wall tumors could be diffi cult. 
Perivascular wall tumors (PWTs) are of  mesenchymal origin and belong to soft tissue 
sarcomas arising from the components of  the perivascular wall [17].
The aim of  this study was reclassifi cation of  dog tumor samples initially diagnosed 
with PNST using histopathological analysis. The main criterion for the reclassifi cation 
was immunohistochemical positivity for various antigens.
MATERIALS AND METHODS
A subset of  17 dogs from the Department of  Pathology medical database was searched 
for diagnoses of  peripheral nerve sheath tumors. Follow-up data including age, sex, 
breed, and location of  the mass, were obtained from referring veterinarians. 
Formalin-fi xed paraffi n embedded tissue samples were cut on 5µm sections and the 
three-step indirect immunohistochemical (IHC) technique was performed. Antigen 
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retrieval was achieved by heating the sections in a microwave oven at 560 W for 21 
minutes in a citrate buffer (pH 6.0). The sections were treated with methanol containing 
0.3% hydrogen peroxide for 15 minutes at room temperature (22±3°C) in order to 
inactivate endogenous peroxidase. Nonspecifi c binding of  secondary antibodies was 
minimized by incubating with 50% normal goat serum in PBS for 20 min. After antigen 
retrieval and inactivation of  endogenous peroxidase, the sections were incubated with 
primary antibodies (Table 1) diluted in phosphate buffer saline (pH 7.2) for 1 h in a 
humid chamber at room temperature (22±3°C). A streptavidin–immunoperoxidase 
staining procedure (Dako) was used for immunolabeling. The immunoreaction was 
visualized with DAB+ (3,3’-diaminobenzidine tetrahydrochloride, DAKO, K3468). 
Sections were counterstained with Mayer’s hematoxylin. Aqueous medium glycergel 
(DAKO, C563) was used on the stained sections for mounting. Appropriate positive 
and negative controls were used. Known canine PNST was used as positive control 
while negative controls were obtained by replacing the primary antibodies by a buffer.
Table 1. Primary antibodies used for immunohistochemical staining
Antibody Source Dilution
S-100 Dako (Z0311) 1:400
α-SMA Dako (M0851) 1:50
Desmin Dako (M0760) 1:100
Vimentin Dako (N1583) RA
GFAP Dako (Z0334) 1:400
Tumors were evaluated according to Ko et al. (2014) [18] considering as positive tumors 
with immunolabeling in more than 10% of  neoplastic cells.
Digital images were made using an optical microscope Olympus BX51 with digital 
camera Olympus Color View III. A reevaluation was made by two pathologists 
separately analyzing hematoxylin and eosin (HE) stained sections using a light 
microscope (BX51, Olympus Optical, Japan).
RESULTS
Histopathology 
Histopathological examination of  tissue samples revealed similar appearance between 
all tumors. PNST were composed of  pleomorphic spindle cells, mostly arranged in 
interwoven bundles, fascicles, whorls and sheets embedded in a collagenous stroma. 
Neoplastic cells had small dark nuclei with prominent nucleoli and moderate mitotic 
activity. They showed marked anisokaryosis. Partly, the areas of  low cellularity and 
abundant myxomatous stroma were present (Figure 1a). In some cases, neoplastic cells 
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infiltrated surrounding tissue, accompanied by lymphocytes and plasma cells. PWTs 
were also composed of  pleomorphic spindle cells with small amounts of  eosinophilic 
cytoplasm arranged in interlacing bundles and concentric whorls separated by the 
collagenous stroma. Few of  them had necrotic areas within the lesion. Mitotic fi gures 
were inconspicuous.  The signifi cant numbers of  infl ammatory cells (eosinophils and 
mast cells) were found around the small vessels (Figure 2a).
Figure 1. Histological and immunohistochemical characteristics of  PNST. a) Pleomorphic 
spindle cells, mostly arranged in interwoven bundles with collagenous stroma and cells with 
prominent nucleoli and moderate mitotic activity, HE, b) Tumor cells negative for α-SMA, c) 
Tumor cells negative for desmin, d) Tumor cells positive for S-100 protein, e) Tumor cells 
positive for GFAP, f) Tumor cells positive for vimentin.
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Immunohistochemistry
Thirteen tumors (76.47%) were negative for muscular markers such as α-smooth 
muscle actin (α-SMA) (Figure 1b) and desmin (Figure 1c) and positive for S-100 protein 
(Figure 1d) and GFAP (Figure 1e). The other four tumors (23.53%) demonstrated 
strong immunoreactivity for α-SMA (both nuclear and cytoplasmic) (Figure 2b) and 
Figure 2. Histological and immunohistochemical characteristics of  PWT. a) Pleomorphic 
spindle cells with small amounts of  eosinophilic cytoplasm arranged in interlacing bundles 
and concentric whorls separated by the collagenous stroma, HE, b) Tumor cells positive for 
α-SMA, c) Tumor cells positive for desmin, d) Tumor cells negative for S-100 protein, e) 
Tumor cells negative for GFAP, f) Tumor cells positive for vimentin.
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desmin (Figure 2c), but were negative for S-100 protein (Figure 2d) and GFAP (Figure 
2e). All tumor samples had strong expression of  vimentin (Figures 1f  and 2f).
Based on IHC results, the 13 tumors that had a positive reaction for neural marker 
S-100 protein remained classifi ed as PNST, while the four cases negative for S-100 
protein and positive for muscular markers were reclassifi ed as PWT. 
DISCUSSION
The similar microscopical appearance of  peripheral nerve sheath tumors and 
perivascular wall tumors often hampers their specifi c differential diagnosis. In this 
study, histologically, PNSTs were composed of  a dense population of  spindle-shaped 
to oval cells arranged in fascicles, whorls or sheets. Partly, the areas of  low cellularity 
and abundant myxomatous stroma were present. According to Gross et al., (2005) [13] 
PNSTs are characterized by well-defi ned cellular component (Antoni A pattern) and 
hypocellular areas with loose fi brous to myxoid stroma (Antoni B pattern).
The current diagnosis and differentiation of  peripheral nerve sheath tumors are 
based mainly on their histological features. However, a histopathological examination 
may be suffi cient for primary diagnosis, but it is usually necessary to perform an 
immunohistochemical analysis in order to distinct PNST from PWT. Besides PWT, 
fi brosarcomas and amelanotic melanomas are often found to be of  signifi cance for 
the differential diagnosis [9].
In the current study, microscopical examination of  these tumors revealed the presence 
of  spindle cells with elongated nuclei arranged in interwoven bundles and fascicles 
embedded in the collagenous stroma with high cell pleomorphism and a moderate 
number of  mitoses. Both Antoni A and Antoni B histological growth patterns were 
observed. A similar pattern was also reported by Chijiwa et al. (2004) [3] and Silva et 
al. (2017) [14]. The concentric whorls were present in PNSTs, but more often were 
observed in PWTs as neoplastic cells surrounding blood vessels rather than collagen 
fi bers. Gaitero et al. (2008) [19] also noted that the concentric pattern in PNSTs was 
not as extensive as that occurring in PWTs.
To date, there is no immunohistochemical marker that is expressed exclusively by 
PNSTs [20]. The immunohistochemical analysis of  the 17 tumor samples in this 
study showed positivity for S-100 protein and glial fi brillary acidic protein in 13 cases. 
Rodriguez et al. (2012) [21] emphasize that PNSTs typically show strong expression of  
S-100 protein, while GFAP is expressed in a subset of  PNSTs. Since the expression 
of  S-100 protein may be present in some other tumors, even in those of  non-neuronal 
origin (such as synovial sarcomas, leiomyosarcomas, and rhabdomyosarcomas), it 
should not be considered as defi nite proof  of  PNST [3,21]. However, the lack of  
S-100 protein expression is described in some cases of  canine MPNSTs [3,19,20]. It 
is explained by the fact that MPNSTs consist of  several cell types and S-100 protein 
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expression will be strong only in tumors consisting predominantly of  Schwann cells 
and a smaller number of  perineural cells and fi broblasts [22].
Alpha-smooth muscle actin, similarly as desmin can be found in cells of  muscle origin 
and tumors originating from these cells. In our study 13 tumor samples of  PNSTs were 
negative for both α- smooth muscle actin and desmin, while 4 tumors were positive 
for one or more muscular markers. Chijiwa et al. (2004) [3] published analogous results 
that none of  PNSTs was positive for α- smooth muscle actin, while 4 of  5 PWTs were 
positive for α-SMA. Although the α-SMA positive cells have not been described in 
benign PNSTs, neoplastic cells with α-SMA expression were observed in malignant 
PNST in the rat [23]. Unlikely PNST, expression of  α-SMA is widely presented in 
tumor cells of  PWT [24]. 
Vimentin is an intermediate fi lament of  mesenchymal cells, so all tumors of  
mesenchymal origin show positive staining. In this study, all tumor samples were 
positive for vimentin. That PNSTs are generally positive for vimentin, revealed also 
Chijiwa et al., 2004 [3] in which study all 100% of  examined tumors were vimentin-
positive, as well as Teixeira et al. 2016 [20] with 95% positive cases, but with different 
expression intensity between the benign and the malignant cases. Negative vimentin 
staining was observed in MPNSTs very rarely and that could be explained by very low 
differentiation of  malignant cells [9].
The patohistological analysis is essential but not suffi cient for the differential 
diagnosis of  PNST and tumors such as fi brosarcomas, PWTs and amelanotic 
melanomas. In agreement with previous manuscripts, the conclusion is that using of  
an immunohistochemical panel for distinguishing PNSTs from PWTs is necessary.
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RAZLIKOVANJE TUMORA OVOJNICA PERIFERNIH NERAVA 
I PERIVASKULARNIH TUMORA KOD PASA UPOTREBOM 
IMUNOHISTOHEMIJSKE METODE
VUČIĆEVIĆ Ivana, MARINKOVIĆ Darko, KUKOLJ Vladimir, NEŠIĆ Slađan, 
ANIČIĆ Milan, ĐURĐEVIĆ Biljana, ALEKSIĆ-KOVAČEVIĆ Sanja
Tumori ovojnica perifernih nerava predstavljaju raznoliku grupu neoplazmi koje vode 
poreklo od ćelija koje obavijaju nerve. Podeljeni su u dve forme: benigni i maligni 
tumori ovojnica perifernih nerava. Iako nisu česti kod domaćih životinja, opisani su 
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kod različitih životinjskih vrsta. Histološki, ovi tumori se sastoje dominantno od vrete-
nastih ćelija koje formiraju snopove, vrtloge i trake, sa različitim brojem pleomorfnih 
ćelija i mitotskih fi gura.
Cilj ovog rada je reklasifi kacija 17 uzoraka tumora pasa prvobitno histološki dijagnos-
tikovanih kao tumori ovojnica perifernih nerava. Glavni kriterijum za reklasifi kaciju 
bio je prisustvo imunohistohemijski pozitivne reakcije na različite antigene.
Tumori ovojnica perifernih nerava su često veoma slični drugim tumorima vretenastih 
ćelija i imunohistohemijsko bojenje je potrebno za diferencijalnu dijagnozu. Tumori 
ovojnica perifernih nerava uglavnom eksprimiraju vimentin, S-100 protein, kiseli gli-
jalni fi brilarni protein, kolagen IV i laminin. 
Od ispitanih tumora, četiri uzorka su bila pozitivna na mišićni marker α-SMA i vimen-
tin i negativna na S-100 i dezmin. U ovim tumorima mestimično su uočene vretenaste 
ćelije koje koncentrično okružuju pojedine krvne sudove, pa su oni reklasifi kovani kao 
perivaskularni tumori. Ostalih 13 tumora su bili S-100 i vimentin pozitivni i α-SMA i 
dezmin negativni i time klasifi kovani kao tumori ovojnica prifernih nerava. 
Upotreba imunohistohemijskog panela je neophodna za razlikovanje tumora ovojnica 
perifernih nerava od perivaskularnih tumora u rutinskoj dijagnostici.
